These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3001465)

  • 1. Dexamethasone suppresses pituitary-adrenal but not behavioral effects of centrally administered CRF.
    Britton DR; Varela M; Garcia A; Rosenthal M
    Life Sci; 1986 Jan; 38(3):211-6. PubMed ID: 3001465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating and 'anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone.
    Britton KT; Lee G; Dana R; Risch SC; Koob GF
    Life Sci; 1986 Oct; 39(14):1281-6. PubMed ID: 3489874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, beta-endorphin, and corticosterone.
    Rivier C; Brownstein M; Spiess J; Rivier J; Vale W
    Endocrinology; 1982 Jan; 110(1):272-8. PubMed ID: 6274623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the long-term administration of corticotropin-releasing factor on the pituitary-adrenal and pituitary-gonadal axis in the male rat.
    Rivier C; Vale W
    J Clin Invest; 1985 Feb; 75(2):689-94. PubMed ID: 2982917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant infusion of ovine corticotropin-releasing hormone does not prevent suppression of the hypothalamus-pituitary-adrenal axis by dexamethasone in male rats.
    Huang TS
    J Endocrinol Invest; 1997; 20(7):393-6. PubMed ID: 9309537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by dexamethasone of the in vivo pituitary response to corticotropin-releasing factor (CRF).
    Russell SM; Dhariwal AP; McCann SM; Yates FE
    Endocrinology; 1969 Sep; 85(3):512-21. PubMed ID: 4307361
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in releasability of ACTH and beta-endorphin with chronic stress.
    Young E; Akil H
    Neuropeptides; 1985 Feb; 5(4-6):545-8. PubMed ID: 2987742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4 phosphodiesterase (PDE-4) inhibitor, denbufylline.
    Hadley AJ; Kumari M; Cover PO; Osborne J; Poyser R; Flack JD; Buckingham JC
    Br J Pharmacol; 1996 Oct; 119(3):463-70. PubMed ID: 8894165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The site of inhibitory action of a natural (corticosterone) and synthetic steroid (dexamethasone) in the hypothalamic-pituitary-adrenal axis.
    Sakakura M; Yoshioka M; Kobayashi M; Takebe K
    Neuroendocrinology; 1981 Mar; 32(3):174-8. PubMed ID: 6261179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of non-peptide corticotropin-releasing factor receptor type 1 antagonist on adrenocorticotropic hormone release and interleukin-1 receptors followed by stress.
    Pournajafi Nazarloo H; Takao T; Nanamiya W; Asaba K; De Souza EB; Hashimoto K
    Brain Res; 2001 May; 902(1):119-26. PubMed ID: 11376601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chronic administration of a CRF(1) receptor antagonist, CRA1000, on locomotor activity and endocrine responses to stress.
    Ohata H; Arai K; Shibasaki T
    Eur J Pharmacol; 2002 Dec; 457(2-3):201-6. PubMed ID: 12464367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of the hypothalamo-pituitary-adrenocortical axis in the rat after long-term dexamethasone treatment.
    Nicholson S; Campbell E; Torrellas A; Beckford U; Altaher R; Sandford R; Scraggs R; Gillham B; Jones M
    Neuroendocrinology; 1984 Oct; 39(4):343-9. PubMed ID: 6092989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of various corticotropin-releasing factor trains on the release of adrenocorticotropin, beta-endorphin, and beta-lipotropin from perifused ovine pituitary cells.
    Evans MJ; Brett JT; McIntosh RP; McIntosh JE; Roud HK; Livesey JH; Donald RA
    Endocrinology; 1985 Sep; 117(3):893-9. PubMed ID: 2990876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine and pituitary-adrenocortical axis activity in the rat.
    Scaccianoce S; Navarra D; Di Sciullo A; Angelucci L; Endröczi E
    Neuroendocrinology; 1989 Oct; 50(4):464-8. PubMed ID: 2812276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of epinephrine and vasopressin in the control of the pituitary-adrenal response to stress.
    Tilders FJ; Berkenbosch F; Vermes I; Linton EA; Smelik PG
    Fed Proc; 1985 Jan; 44(1 Pt 2):155-60. PubMed ID: 2981737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism.
    Smith SM; Vaughan JM; Donaldson CJ; Rivier J; Li C; Chen A; Vale WW
    Endocrinology; 2004 Nov; 145(11):5202-9. PubMed ID: 15271883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic maternal dexamethasone treatment on the hormones of the hypothalamo-pituitary-adrenal axis in the rat fetus.
    Dupouy JP; Chatelain A; Boudouresque F; Conte-Devolx B; Oliver C
    Biol Neonate; 1987; 52(4):216-22. PubMed ID: 2823915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercorticosteronuria and diminished pituitary responsiveness to corticotropin-releasing factor in obese Zucker rats.
    Cunningham JJ; Calles-Escandon J; Garrido F; Carr DB; Bode HH
    Endocrinology; 1986 Jan; 118(1):98-101. PubMed ID: 2934245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary-adrenal axis responses to acute amphetamine in the rat.
    Swerdlow NR; Koob GF; Cador M; Lorang M; Hauger RL
    Pharmacol Biochem Behav; 1993 Jul; 45(3):629-37. PubMed ID: 8392732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.